PMCT
PharmaCountry
+ Create
EN
Demands
Home
Products
Services
Jobs
Seekers
No categories for this tab
Retry
Regulatory Updates | Pharmacountry Insights
Home
/
Insights
/
Regulatory Updates
Regulatory Updates
FDA, EMA, TGA and global regulatory developments
#EMTRICITABINE
×
Daily News
Market Analysis
Research & Reports
Regulatory Updates
UPDATED
Regulatory Updates
Sep 15, 2026
•
3 min read
FDA Approves Aurobindo Pharma’s Generic EMTRICITABINE (ANDA 079188)
The FDA has approved Aurobindo Pharma’s oral 200 mg EMTRICITABINE capsule under ANDA 079188, confirming its prescription status.